Standardised from the company’s filings, newest period first, labelled with the company’s own fiscal calendar. A line the company does not report is left off rather than shown as zero; margins and free cash flow are worked out here, and only where every input is present.
| Line item | Q1 FY272026-08-31 | Q4 FY262026-05-31 | Q3 FY262026-02-28 | Q2 FY262025-11-30 | Q1 FY262025-08-31 | Q4 FY252025-05-31 | Q3 FY252025-02-28 | Q2 FY252024-11-30 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $19.35B | $19.18B | $17.19B | $16.06B | $14.93B | $15.90B | $14.13B | $14.06B |
| Cost of revenue | $7.73B | $6.67B | $6.09B | $5.37B | $4.88B | $4.74B | $4.20B | $4.09B |
| Gross profit | $11.61B | $12.51B | $11.10B | $10.68B | $10.04B | $11.16B | $9.94B | $9.97B |
| Gross margin | 60.0% | 65.2% | 64.6% | 66.5% | 67.3% | 70.2% | 70.3% | 70.9% |
| Research and development | $2.40B | $2.61B | $2.61B | $2.56B | $2.49B | $2.65B | $2.43B | $2.47B |
| Selling, general and administrative | $2.19B | $2.51B | $2.44B | $2.56B | $2.44B | $2.77B | $2.51B | $2.58B |
| Operating expenses | $4.88B | $6.38B | $5.63B | $5.95B | $5.77B | $6.05B | $5.58B | $5.75B |
| Operating income | $6.73B | $6.13B | $5.46B | $4.73B | $4.28B | $5.11B | $4.36B | $4.22B |
| Operating margin | 34.8% | 32.0% | 31.8% | 29.5% | 28.7% | 32.1% | 30.8% | 30.0% |
| EBITDA | $10.18B | $6.19B | $11.81B | $7.27B | $6.46B | $3.51B | $9.37B | $5.83B |
| Interest expense | −$1.43B | −$1.44B | −$1.18B | −$1.06B | −$923.00M | −$978.00M | −$892.00M | −$866.00M |
| Income before taxes | $5.61B | $5.37B | $4.42B | $6.34B | $3.43B | $4.15B | $3.45B | $3.39B |
| Income taxes | $847.00M | $1.07B | $695.00M | $207.00M | $500.00M | $725.00M | $512.00M | $239.00M |
| Net income | $4.76B | $4.30B | $3.72B | $6.14B | $2.93B | $3.43B | $2.94B | $3.15B |
| Net margin | 24.6% | 22.4% | 21.6% | 38.2% | 19.6% | 21.5% | 20.8% | 22.4% |
| EPS, basic | $1.58 | $1.47 | $1.29 | $2.14 | $1.04 | $1.22 | $1.05 | $1.13 |
| EPS, diluted | $1.56 | $1.45 | $1.27 | $2.10 | $1.01 | $1.19 | $1.02 | $1.10 |
| Diluted shares | 3.00B | 2.91B | 2.91B | 2.92B | 2.91B | 2.87B | 2.87B | 2.87B |
Figures describe Oracle shares, not any token. As of Sep 11, 2026, from Massive's standardised financials. The company reports these figures; a token's issuer holds the shares and reports nothing of its own here.
